Results 161 to 165 of about 192 (165)

The effect of a novel cardioprotector AAA-135 on the morphology and function in a viral model of cardiomyopathy

Journal of Cardiac Failure, 1998
Geoffrey Puley, Fayez Dawood, Wen-Hu Wen, David Hou, Peter Backx, Michael J. Sole, Karen Aitken, Peter Liu   +7 more
openaire   +1 more source

Тhe use of sevofluran as cardioprotector for newborns in transposition of the great arteries correction surgery with cardiopulmonary bypass

Clinical Physiology of Circulation, 2019
O.A. Stepanicheva, M.M. Rybka, D.Ya. Khinchagov, K.V. Mumladze, M.V. Lomakin, A.S. Loseva, A.A. Goncharov, E.A. Rogal’skaya   +7 more
openaire   +1 more source

MILDRONATE, CEREBROCRAST, AND GLUTAPYRONE AS HIGHLY ACTIVE CARDIOPROTECTORS IN THE AZT-INDUCED CARDIOMYOPATHY IN MICE

2005
Svirskis, Simons, Isajevs, Sergejs, Rumaks, Juris, Gordjushina, Valentina, Taivans, Immanuels, Viksna, Ludmila, Kalvinsh, Ivars, Gunars Duburs, Jansone, Baiba, Klusa, Vija   +9 more
openaire   +1 more source

Cyclosporine A-induced myocardial damage: is the insulin a cardioprotector?

2004
REZZANI, Rita, BUFFOLI, Barbara, GIUGNO L, DESSY C, FERON O, BIANCHI R.   +5 more
openaire   +1 more source

4010-3. PREVALENCIA DE USO DE FÁRMACOS CARDIOPROTECTORES EN PACIENTES CON SCASEST

Revista Española de Cardiología
María Thiscal López Lluva, Pablo Díez Villanueva, Felipe Díez del Hoyo, Martín Negreira Caamaño, Clea González Maniega, María Fernández González, Laura Fuertes Kenneally, Lucía Matute Blanco, Jessica Vaquero Luna, Clara Fernández Cordón, Pedro Luis Cepas Guillén   +10 more
openaire   +1 more source